Description
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone, commonly abbreviated to GHRH. It is supplied as a lyophilised (freeze-dried) vial for laboratory research and educational use only.
Each batch is produced to 99%+ purity, with third-party sample testing and full Certificate of Analysis support for mass and purity, helping researchers assess the identity, quality and consistency of the materials supplied.
Reported Areas of Research Interest
Tesamorelin has been investigated for its interaction with GHRH receptors in the pituitary gland and its reported ability to stimulate the natural release of growth hormone, subsequently influencing insulin-like growth factor 1, commonly known as IGF-1.
Scientific research involving tesamorelin has explored areas including:
- Growth hormone and IGF-1 signalling
- Visceral adipose tissue regulation
- Abdominal fat distribution
- Lipid and triglyceride metabolism
- Liver-fat and metabolic-health markers
- Body-composition pathways
- Pituitary and endocrine-system function
Clinical studies have primarily examined tesamorelin in adults living with HIV who developed excess abdominal visceral fat associated with lipodystrophy. Research has reported reductions in visceral adipose tissue, with some studies also investigating changes in liver fat, triglycerides and other metabolic markers.
These findings relate to specific clinical populations and controlled research environments. They should not be interpreted as evidence that tesamorelin is a general weight-loss treatment, bodybuilding product or suitable intervention for otherwise healthy individuals.
Bacteriostatic water and research accessories are sold separately.
For research purposes only. Not for human or animal consumption, or for clinical, diagnostic or therapeutic use.






Reviews
There are no reviews yet.